European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease–the SHARE initiative

N de Graeff, N Groot, S Ozen, D Eleftheriou… - …, 2019 - academic.oup.com
Abstract Objectives The European Single Hub and Access point for paediatric
Rheumatology in Europe initiative aimed to optimize care for children with rheumatic …

Dissecting Kawasaki disease: a state-of-the-art review

SM Dietz, D Van Stijn, D Burgner, M Levin… - European journal of …, 2017 - Springer
Kawasaki disease (KD) is a pediatric vasculitis with coronary artery aneurysms (CAA) as its
main complication. The diagnosis is based on the presence of persistent fever and clinical …

Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study

K Miyata, T Kaneko, Y Morikawa… - The Lancet Child & …, 2018 - thelancet.com
Background The RAISE study showed that additional prednisolone improved coronary
artery outcomes in patients with Kawasaki disease at high risk of intravenous …

Kawasaki disease

CM Hedrich, A Schnabel, T Hospach - Frontiers in pediatrics, 2018 - frontiersin.org
Kawasaki disease (KD) is an acute-onset systemic vasculitis of medium-sized vessels that
mostly affects infants and toddlers. Globally, it is the most common form of childhood primary …

Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015

RMR Tulloh, R Mayon-White, A Harnden… - Archives of disease in …, 2019 - adc.bmj.com
Objective Kawasaki disease (KD) is an increasingly common vasculitis with risk of coronary
artery aneurysms (CAAs). The last UK survey was in 1990, whereas current epidemiology …

Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases

X Li, Y Chen, Y Tang, Y Ding, Q Xu, L Sun… - European journal of …, 2018 - Springer
The purpose of this study was to identify the clinical features and laboratory factors that are
predictive of intravenous immunoglobulin (IVIG)-resistant Kawasaki disease. Multiple …

Describing Kawasaki shock syndrome: results from a retrospective study and literature review

A Taddio, ED Rossi, L Monasta, S Pastore… - Clinical …, 2017 - Springer
Kawasaki shock syndrome (KSS) is a rare manifestation of Kawasaki disease (KD)
characterized by systolic hypotension or clinical signs of poor perfusion. The objectives of …

Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development.(2011-2016): KAWA-RACE study group

E Fernandez-Cooke, A Barrios Tascón… - PLoS …, 2019 - journals.plos.org
Background Kawasaki disease (KD) is an acute self-limited systemic vasculitis of unknown
etiology affecting mainly children less than 5 years of age. Risk factors for cardiac …

Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease

M Piram, M Darce Bello, S Tellier, S Di Filippo… - Scientific reports, 2020 - nature.com
Abstract About 10–20% of patients with Kawasaki disease (KD) are unresponsive to
intravenous immunoglobulin (IVIg) and are at increased risk of coronary artery abnormalities …

Prediction models for intravenous immunoglobulin resistance in Kawasaki disease: a meta-analysis

Y Kuniyoshi, Y Tsujimoto, M Banno, S Taito, T Ariie… - …, 2023 - publications.aap.org
Prediction Models for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Meta-analysis
| Pediatrics | American Academy of Pediatrics Skip to Main Content Disclaimer » Advertising …